Myelodysplastic Syndromes (MDS)

Ryan J. Mattison, MD

Institution
University of Wisconsin Health
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelomonocytic Leukaemia (CMML)
Graft Versus Host Disease (GVHD)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pure Red Cell Aplasia (PRCA)
About
Dr Mattison is an associate professor of medicine within the division of hematology/oncology at the University of Wisconsin School of Medicine and Public Health. He earned his medical degree at the University of Iowa Carver College of Medicine, Iowa City, IA. He completed his residency at University of North Carolina Hospitals, Chapel Hill, NC and his fellowship at the University of Chicago Hospitals, Chicago, IL. Dr. Mattison is board-certified in internal medicine, medical oncology and hematology.

Cecilia Arana Yi, MD, MSHS, FACP

Institution
Mayo Clinic, Phoenix, AZ
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelomonocytic Leukaemia (CMML)
Graft Versus Host Disease (GVHD)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pure Red Cell Aplasia (PRCA)

Shannon McCurdy, MD

Institution
University of Pennsylvania
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Shannon McCurdy, MD is Assistant Professor of Medicine at the Hospital of the University of Pennsylvania and is employed by Penn Medicine . Dr. McCurdy is board certified in Internal Medicine and Medical Oncology. She is an active researcher and works with the Bone Marrow and Stem Cell Transplant Program, the Hematological Malignancies (Blood Cancer) Program and the Leukemia Program.

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis

In a systematic review and meta-analysis, we compared allogeneic transplant outcomes after myeloablative conditioning (MAC) versus reduced-intensity conditioning (RIC) in patients with

Subscribe to Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.